サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463557

中南米の体外診断：2030年までの市場予測 - 地域分析 - 製品・サービス、技術、用途、エンドユーザー別

South & Central America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

出版日
ページ情報
英文 113 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
中南米の体外診断：2030年までの市場予測 - 地域分析 - 製品・サービス、技術、用途、エンドユーザー別
出版日: 2024年01月24日
発行: The Insight Partners
ページ情報: 英文 113 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の体外診断市場は、2022年の58億7,417万米ドルから2030年には84億7,811万米ドルに成長すると予測されています。2022年から2030年までのCAGRは4.7%と推定されます。

IVD技術とデジタルヘルスソリューションの統合が中南米の体外診断市場を後押し

体外診断は、臨床、検査室、外来で使用され、特に病気の発見に役立ち、その結果、適切な治療プロトコルの選択に役立つことを目的としています。IVD技術とデジタルヘルスソリューションの統合は、世界的に牽引力を増しています。データ分析、人工知能、遠隔モニタリングは診断検査の価値を高め、患者管理と転帰の改善につながります。デジタルヘルスソリューションと統合された体外診断用医薬品技術は、臨床意思決定支援システムに組み込むことができます。WHOが認識しているように、デジタルヘルス・ソリューションは病気の発見に役立つ可能性があります。人工知能を用いた健康ボットやその他同様の新たなソリューションは、患者ケアに機会をもたらし、高コストや時間要件などの課題に対処する可能性があります。ゲノム検査に基づく診断では、ディープラーニングは、特定のサンプルの画像から、がん細胞を特定し、そのタイプを決定し、腫瘍にどのような変異が起こるかを予測することができます。体外診断における人工知能と機械学習（AI/ML）は、医療機器開発に革命をもたらしています。これらの最新の診断システムは、デジタル画像解析に基づく診断を容易にし、それによってヘルスケアの意思決定を改善します。スマート診断薬は、人工知能を利用することで、検査室ベースの診断薬よりも優れた性能をわずかな価格で実現する、極めて拡張性の高い体外診断ソリューションです。さらに、この種の診断薬は、独自の化学的・生物学的シグネチャーの検出と分析により、創発的な特徴を導き出すことができます。このように、体外診断とデジタルヘルス技術の統合は、今後数年間、体外診断市場に有利な機会を提供する可能性が高いです。

中南米の体外診断市場概要

中南米の体外診断市場は、ブラジル、アルゼンチン、その他南米に区分されます。同地域の体外診断市場は、慢性疾患の有病率の高さ、診断施設の増加、新興国市場のヘルスケアインフラの発展により、予測期間中の成長が見込まれています。中南米地域における体外診断市場の成長には、前述のような要因が影響しています。ブラジルは中南米最大の市場です。支援的な政府、有利なヘルスケア政策、新興経済諸国、先進的なヘルスケアインフラなどの要因が、診断における最新技術の採用余地を生み出しています。さらに、慢性疾患や感染症の流行が増加していることも、同国の体外診断市場の成長を促進すると予測されています。国際糖尿病連合が発表した調査によると、ブラジルの糖尿病人口は2021年の1,570万人から2045年には2,180万人に達すると予測されています。また、推計によると、ブラジルの糖尿病人口は世界第5位です。体外診断市場の大手企業の多くは、ブラジルでの地理的拡大を通じて市場を強化する戦略的イニシアチブをとっています。例えば、2022年8月、フレゼニウス・カビはBio-Manguinhos/FiocruzおよびBionovisと提携し、ブラジルでアダリムマブのバイオシミラーへのアクセスを提供します。この提携により、ブラジルの公的医療制度（SUS）におけるいくつかの自己免疫疾患の治療選択肢が拡大します。

さらに、ブラジルは老人人口の高い増加率を目の当たりにしています。例えば、汎米保健機構（Pan American Health Organization）によると、ブラジルの60歳以上の高齢者は3,000万人を超えており、これは同国の人口の13％に相当します。個別化医療の開発・実施における分子診断技術の活用は、ブラジル市場の成長を後押しすると思われます。2020年2月28日、セファイドとシャーロック・バイオサイエンシズは、新たな最先端分子診断検査の開発を模索するために提携しました。この提携は、腫瘍学的疾患と感染症に対する分子診断検査の開発に重点を置く。ブラジルはラテンアメリカ最大のヘルスケア市場で、GDPの9.1%をヘルスケアに費やしています。2021年、ブラジルは医療機器の輸入を7.3％増やし、62億米ドルに達します。ブラジル政府はヘルスケア製品の主要な買い手であり、公的医療制度に製品を供給しています。国際貿易局によると、2021年には3億1,700万米ドルのCBDL体外診断用試薬・機器がブラジルに輸入されました。このように、新興経済諸国と糖尿病蔓延の拡大は、ブラジルの体外診断市場の成長を後押ししています。

中南米の体外診断市場の収益と2030年までの予測（金額）

中南米の体外診断市場セグメンテーション

中南米の体外診断市場は、製品・サービス、技術、用途、エンドユーザー、国に区分されます。

製品＆サービス別では、中南米の体外診断市場は試薬＆キット、機器、ソフトウェア＆サービスに区分されます。2022年の中南米の体外診断市場では、試薬＆キット部門が最大のシェアを占めています。

技術別では、中南米の体外診断市場は免疫測定/免疫化学、臨床化学、分子診断、微生物学、血糖自己測定、凝固・止血、血液学、尿検査、その他に区分されます。2022年の中南米の体外診断市場では、免疫測定/免疫化学分野が最大のシェアを占めました。

用途別では、中南米の体外診断市場は感染症、糖尿病、腫瘍、心臓病、自己免疫疾患、腎臓病、その他に区分されます。2022年の中南米体外診断市場では、感染症分野が最大のシェアを占めています。

エンドユーザー別に見ると、中南米の体外診断市場は病院、研究所、在宅医療、その他に区分されます。病院セグメントが2022年の中南米体外診断市場で最大のシェアを占めています。

国別では、中南米の体外診断市場はブラジル、アルゼンチン、その他南米に区分されます。2022年の中南米体外診断市場はブラジルが独占。

Abbott Laboratories、Becton Dickinson and Co、bioMerieux SA、Bio-Rad Laboratories Inc、Danaher Corp、F. Hoffmann-La Roche Ltd、Qiagen NV、Siemens AG、Sysmex Corp、Thermo Fisher Scientific Incは、南米・中南米の体外診断市場に参入している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の体外診断市場- 主要産業力学

  • 市場促進要因
    • 慢性疾患および感染症の有病率の増加
    • ポイントオブケア検査の成長とCOVID-19パンデミック時の体外診断需要の急増
  • 市場抑制要因
    • 規制体制と償還政策の不備
  • 市場機会
    • IVDとデジタルヘルス技術の統合
  • 今後の動向
    • 個別化医療とゲノミクスへの需要の高まり

第5章 臨床検査市場：中南米市場分析

  • 中南米の体外診断市場収益、2022年～2030年

第6章 南米・中米の体外診断市場：収益と2030年までの予測：製品・サービス別

  • 市場収益シェア、2022年および2030年
  • 試薬・キット
  • ソフトウェアとサービス
  • 検査機器

第7章 南米・中米の体外診断市場：収益と2030年までの予測：技術別

  • 市場収益シェア、2022年および2030年
  • 免疫測定/免疫化学
  • 臨床化学
  • 分子診断学
  • 微生物学
  • 血糖自己測定
  • 凝固および止血
  • 血液学
  • 尿検査
  • その他

第8章 中南米の体外診断市場：収益と2030年までの予測：用途別

  • 市場収益シェア、2022年および2030年
  • 感染症
  • 糖尿病
  • 腫瘍学
  • 循環器
  • 自己免疫疾患
  • 腎臓内科
  • その他

第9章 中南米の体外診断市場：収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院
  • 研究所
  • 在宅医療
  • その他

第10章 中南米の体外診断市場：収益と2030年までの予測：国別分析

  • ブラジル
  • アルゼンチン
  • その他中南米

第11章 業界情勢

  • 有機的開発
  • 無機的展開

第12章 企業プロファイル

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Danaher Corp
  • Siemens AG
  • Sysmex Corp
  • Thermo Fisher Scientific Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Qiagen NV

第13章 付録

図表

List Of Tables

  • Table 1. South & Central America In-Vitro Diagnostics Market Segmentation
  • Table 2. Brazil South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Brazil South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Argentina South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Argentina South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Argentina South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Organic Developments Done by Companies
  • Table 15. Inorganic Developments Done by Companies
  • Table 16. Glossary of Terms, South & Central America In-Vitro Diagnostics Market

List Of Figures

  • Figure 1. South & Central America In-Vitro Diagnostics Market Segmentation, By Country
  • Figure 2. South & Central America In-Vitro Diagnostics Market: Key Industry Dynamics
  • Figure 3. South & Central America In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. South & Central America In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 6. Reagents and Kits: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Software and Services: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Instruments: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. South & Central America In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 10. Immunoassay/ Immunochemistry: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Clinical Chemistry: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Molecular Diagnostics: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microbiology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Blood Glucose Self-Monitoring: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Coagulation and Hemostasis: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hematology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Urinalysis: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 20. Infectious Diseases: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diabetes: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Oncology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Cardiology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Autoimmune Diseases: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Nephrology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. South & Central America In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Laboratories: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Homecare: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. South & Central America: South & Central America In-Vitro Diagnostics Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 33. South & Central America In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 34. Brazil: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Argentina: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Rest of South & Central America: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
目次
Product Code: TIPRE00022126

The South & Central America in-vitro diagnostics market is expected to grow from US$ 5,874.17 million in 2022 to US$ 8,478.11 million by 2030. It is estimated to grow at a CAGR of 4.7% from 2022 to 2030.

Integration of IVD Technologies with Digital Health Solutions Fuels South & Central America In-Vitro Diagnostics Market

IVD is used in clinical, laboratory, and outpatient settings with the aim specifically to help in the detection of diseases and, consequently, aid in the selection of appropriate treatment protocols. The integration of IVD technologies with digital health solutions is gaining traction globally. Data analytics, artificial Intelligence, and remote monitoring enhance the value of diagnostic tests, leading to better patient management and outcomes. IVD technologies integrated with digital health solutions can be incorporated into clinical decision support systems. As recognized by the WHO, digital health solutions could help detect diseases. Artificial intelligence health bots and similar other emerging solutions may present opportunities for patient care and address challenges such as high cost and time requirements. In diagnostics based on genomic testing, deep learning can identify cancer cells, determine their type, and predict what mutations may occur in a tumor from images of a specific sample. Artificial intelligence and machine learning (AI/ML) in in-vitro diagnostics are revolutionizing medical device development. These modern diagnostic systems facilitate diagnosis based on digital image analysis, thereby improving healthcare decision-making. Smart diagnostics are extremely scalable IVD solutions that use artificial intelligence to perform better than lab-based diagnostics at a fraction of the price. Additionally, this type of diagnostics can derive emergent features through unique chemical and biological signature detection and analysis. Thus, the integration of IVD with digital health technologies is likely to offer lucrative opportunities to the in-vitro diagnostics market in the coming years.

South & Central America In-Vitro Diagnostics Market Overview

The South & Central America in-vitro diagnostics market has been segmented into Brazil, Argentina, and the Rest of South & Central America. The market for in-vitro diagnostics in the region is expected to grow during the forecast period owing to the higher prevalence of chronic conditions, increasing number of diagnostic facilities, and developing healthcare infrastructure. The aforementioned factors are responsible for influential growth of in-vitro diagnostics market in the South & Central America region. Brazil is the largest market in South & Central America. Factors such as supportive government, lucrative healthcare policies, a developing economy, and advancing healthcare infrastructure create scope for adopting modern technologies in diagnostics. Additionally, the increasing prevalence of chronic conditions and infectious diseases is projected to drive the growth of the in-vitro diagnostics market in the country. According to a study published by the International Diabetes Federation, the diabetic population of the country is projected to reach 21.8 million by 2045 from 15.7 million in 2021. Also, according to the estimates, Brazil has the fifth largest diabetic population in the world. A number of major players in the in-vitro diagnostics market take strategic initiatives to consolidate their market through geographic expansions in Brazil. For instance, in August 2022, Fresenius Kabi partnered with Bio-Manguinhos/Fiocruz and Bionovis to provide access to adalimumab biosimilar in Brazil. This partnership will expand treatment options for several autoimmune diseases in the Brazilian Public Health System (SUS).

Additionally, Brazil is witnessing a high rate of growth in the geriatric population. For instance, according to the Pan American Health Organization, Brazil has more than 30 million people aged 60 years or more, which represents 13% of the country's population. The use of molecular diagnostic techniques in developing and, subsequently, administering personalized medicine is likely to boost the market growth in Brazil. On February 28, 2020, Cepheid and Sherlock Biosciences collaborated to explore the development of new cutting-edge molecular diagnostic tests. The collaboration will focus on the development of molecular diagnostic tests for oncological conditions and infectious diseases. Brazil is the largest healthcare market in Latin America, spending 9.1% of its GDP on healthcare. In 2021, Brazil added the imports of medical devices by 7.3%, reaching US$ 6.2 billion. The Government of Brazil is a key buyer of healthcare products, which supply them to the public healthcare system. As per the International Trade Administration ~US$ 317 million CBDL in vitro diagnostic reagents and equipment were imported into Brazil in 2021. Thus, the developing economy and growing diabetes prevalence fuels the in-vitro diagnostics market growth in Brazil.

South & Central America In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America In-Vitro Diagnostics Market Segmentation

The South & Central America in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.

Based on product & services, the South & Central America in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the South & Central America in-vitro diagnostics market in 2022.

Based on technology, the South & Central America in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the South & Central America in-vitro diagnostics market in 2022.

Based on application, the South & Central America in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the South & Central America in-vitro diagnostics market in 2022.

Based on end user, the South & Central America in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the South & Central America in-vitro diagnostics market in 2022.

Based on country, the South & Central America in-vitro diagnostics market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America in-vitro diagnostics market in 2022.

Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America in-vitro diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America In-Vitro Diagnostics Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
    • 4.1.2 Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic
  • 4.2 Market Restraint
    • 4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
  • 4.3 Market Opportunities
    • 4.3.1 Integration of IVD with Digital Health Technologies
  • 4.4 Future Trends
    • 4.4.1 Increasing Demand for Personalized Medicine and Genomics

5. In-Vitro Diagnostics Market - South & Central America Market Analysis

  • 5.1 South & Central America In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 6.1 Overview
  • 6.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 6.3 Reagents and Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Kits: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Software and Services
    • 6.4.1 Overview
    • 6.4.2 Software and Services: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Instruments
    • 6.5.1 Overview
    • 6.5.2 Instruments: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Immunoassay/ Immunochemistry
    • 7.3.1 Overview
    • 7.3.2 Immunoassay/ Immunochemistry: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Clinical Chemistry
    • 7.4.1 Overview
    • 7.4.2 Clinical Chemistry: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Molecular Diagnostics
    • 7.5.1 Overview
    • 7.5.2 Molecular Diagnostics: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Microbiology
    • 7.6.1 Overview
    • 7.6.2 Microbiology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Blood Glucose Self-Monitoring
    • 7.7.1 Overview
    • 7.7.2 Blood Glucose Self-Monitoring: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Coagulation and Hemostasis
    • 7.8.1 Overview
    • 7.8.2 Coagulation and Hemostasis: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Hematology
    • 7.9.1 Overview
    • 7.9.2 Hematology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Urinalysis
    • 7.10.1 Overview
    • 7.10.2 Urinalysis: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.11 Others
    • 7.11.1 Overview
    • 7.11.2 Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Infectious Disease
    • 8.3.1 Overview
    • 8.3.2 Infectious Diseases: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Diabetes
    • 8.4.1 Overview
    • 8.4.2 Diabetes: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Oncology
    • 8.5.1 Overview
    • 8.5.2 Oncology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Autoimmune Diseases
    • 8.7.1 Overview
    • 8.7.2 Autoimmune Diseases: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Nephrology
    • 8.8.1 Overview
    • 8.8.2 Nephrology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Laboratories
    • 9.4.1 Overview
    • 9.4.2 Laboratories: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Homecare
    • 9.5.1 Overview
    • 9.5.2 Homecare: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 South & Central America In-Vitro Diagnostics Market
    • 10.1.1 Overview
    • 10.1.2 South & Central America In-Vitro Diagnostics Market, by Country
      • 10.1.2.1 Brazil: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.3 Brazil: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.1.4 Brazil: South & Central America In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.1.5 Brazil: South & Central America In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.1.6 Brazil: South & Central America In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Argentina: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.3 Argentina: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Argentina: South & Central America In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Argentina: South & Central America In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.6 Argentina: South & Central America In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.3 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.3.4 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.3.5 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.3.6 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

11. Industry Landscape

  • 11.1 Organic Developments
    • 11.1.1 Overview
  • 11.2 Inorganic Developments
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Danaher Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Siemens AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Sysmex Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Thermo Fisher Scientific Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 bioMerieux SA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Bio-Rad Laboratories Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Qiagen NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms